CTD 6.25 Tablet
By CTD
Rx
15 Tablet in a Strip

Composition
Chlorthalidone(6.25mg)

Manufacturer - Ipca Laboratories Ltd
142 AB, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, Maharashtra

Expires on or after
April, 2026

liver
When using CTD 6.25 Tablet, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when taking CTD 6.25 Tablet, so it is essential to consult your doctor before starting the medication. It is advised not to use CTD 6.25 Tablet in patients with severe liver disease. Always seek guidance from your healthcare provider if you have concerns about using this medication with liver conditions.

kidney
CTD 6.25 Tablet may require dose adjustment in severe kidney disease. It is not recommended for these patients. Please consult your doctor.

alcohol
CTD 6.25 Tablet can lead to increased drowsiness when taken with alcohol. It's important to be cautious.

driving
When taking CTD 6.25 Tablet, be cautious while driving as it may reduce alertness, impact vision, or cause drowsiness and dizziness. Avoid driving if experiencing these side effects.

pregnancy
CTD 6.25 Tablet should be used with caution during pregnancy. Limited human studies suggest potential harm to the baby. Your doctor will evaluate the benefits and risks before prescribing. Please consult your doctor before use.

breastfeeding
During breastfeeding, use CTD 6.25 Tablet with caution. Pause breastfeeding until the mother's treatment is finished and the drug is cleared from her body to avoid accumulation in the infant.
Habit Forming | No |
Chemical Class | Thiazide (Related heterocyclics) |
Therapeutic Class | CARDIAC |
Action Class | Low-ceiling Diuretics (Inhibitors of Na+Cl symport) |
₹113.1
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024